Probable quetiapine-mediated prolongation of the QT interval

Journal of Pharmacy Practice

Volumn 24, Issue 5, 2011, Pages 506-512

  Aghaienia, Nasim ^a   Brahm, Nancy C ^a   Lussier, Kyla M ^a   Washington, Nicole B ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

antipsychotic; psychotropic; QT interval; QTc prolongation; quetiapine

Indexed keywords

ATORVASTATIN; FAMOTIDINE; LORAZEPAM; MEDROXYPROGESTERONE; MONTELUKAST; OMEPRAZOLE; PALIPERIDONE; PAROXETINE; PIPERAZINE ESTRONE SULFATE; QUETIAPINE; SITAGLIPTIN; TRIHEXYPHENIDYL; VALDECOXIB; VALPROATE SEMISODIUM; VITAMIN D; ZIPRASIDONE;

ANEMIA; ARTICLE; BALANCE DISORDER; COGNITION; CONFUSION; DELIRIUM; DISABILITY; DIVORCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; GASTROINTESTINAL HEMORRHAGE; HOSPITAL READMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRANSAMINASEMIA; HYPOKALEMIA; LOBAR PNEUMONIA; MOOD DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; QT INTERVAL; QT PROLONGATION; REHYDRATION; SCHIZOAFFECTIVE PSYCHOSIS; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA;

EID: 83455255470     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190011415683     Document Type: Article

References (48)

1. Seroquel [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals ; 2005 :
2. Taylor DM. Antipsychotics and QT prolongation. Acta Psychiatr Scand. 2003 ; 107: 85-95 (Pubitemid 36164475)
3. Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. Psychiatr Q. 2003 ; 74: 291-306 (Pubitemid 38115323)
4. Viskin S, Justo D, Halkin A, et al. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis. 2003 ; 45: 415-427 (Pubitemid 36403114)
5. Vieweg WV. New generation antipsychotic drugs and QTc interval prolongation. Prim Care Companion J Clin Psychiatry. 2003 ; 5: 205-215
6. Stollberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005 ; 20: 243-251 (Pubitemid 41192144)
7. Alvarez PA, Pahissa J. QT alterations in psychopharmacology: proven candidates and suspects. Curr Drug Saf. 2010 ; 5: 97-104
8. Fogel J, Diaz JE. Olanzapine overdose. Ann Emerg Med. 1998 ; 32: 275-276
9. Leo R, Razzini C, Di Lorenzo G, et al. Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol. J Clin Psychiatry. 2008 ; 69: 327-328 (Pubitemid 351469281)
10. Roman M, Farmer SY. Antipsychotic medications and cardiac conduction risks. Issues Ment Health Nurs. 2010 ; 31: 68-70
11. ChiltonRTalbertRL. Cardiovascular testing. In: JosephTDiPiroRLTYeeGCMatzkeGRWellsBGMichael PoseyL eds. Pharmacotherapy: A Pathophysiologic Approach, 7e. 2008. http://www.accesspharmacy.com/content.aspx? aID=3196343. Accessed December 3, 2010.
12. Harrigan EP, Miceli JJ, Anziano R, et al. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol. 2004 ; 24: 62-69 (Pubitemid 38134167)
13. Kaab S, Pfeufer A, Hinterseer M, et al. Long QT syndrome. Why does sex matter?. Z Kardiol. 2004 ; 93: 641-645 (Pubitemid 39304387)
14. Cardoso CR, Salles GF, Deccache W. QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus. Stroke. 2003 ; 34: 2187-2194 (Pubitemid 37099834)
15. Sala M, Vicentini A, Brambilla P, et al. QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry. 2005 ; 4: 1
16. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992 ; 8: 690-695
17. Raghu KG, Singh R, Prathapan A, et al. Modulation of haloperidol induced electrophysiological alterations on cardiac action potential by various risk factors and gender difference. Chem Biol Interact. 2009 ; 180: 454-459
18. Hatta K, Takahashi T, Nakamura H, et al. Prolonged QT interval in acute psychotic patients. Psychiatry Res. 2000 ; 94: 279-285 (Pubitemid 30417618)
19. Letsas KP, Efremidis M, Kounas SP, et al. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol. 2009 ; 98: 208-212
20. SanoskiCASchoenMDBaumanJL. The Arrhythmias. In: JosephTDiPiroRLTYeeGCMatzkeGRWellsBGMichael PoseyL eds. Pharmacotherapy: A Pathophysiologic Approach, 7e. 2008. http://www.accesspharmacy.com/content.aspx? aID=3198567. Accessed December 3, 2010.
21. Balit CR, Isbister GK, Hackett LP, et al. Quetiapine poisoning: a case series. Ann Emerg Med. 2003 ; 42: 751-758 (Pubitemid 37486794)
22. Hunfeld NG, Westerman EM, Boswijk DJ, et al. Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases. Ther Drug Monit. 2006 ; 28: 185-189 (Pubitemid 44314947)
23. Ngo A, Ciranni M, Olson KR. Acute quetiapine overdose in adults: a 5-year retrospective case series. Ann Emerg Med. 2008 ; 52: 541-547
24. Isbister GK, Duffull SB. Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal. Int Clin Psychopharmacol. 2009 ; 24: 174-180
25. Hustey FM. Acute quetiapine poisoning. J Emerg Med. 1999 ; 17: 995-997 (Pubitemid 29528071)
26. Bodmer M, Burkard T, Kummer O, et al. Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose. Ther Drug Monit. 2008 ; 30: 553-556
27. Vivek S. No QT interval prolongation associated with quetiapine overdose. Am J Emerg Med. 2004 ; 22: 330 (Pubitemid 38918262)
28. Fernandes PP, Marcil WA. Death associated with quetiapine overdose. Am J Psychiatry. 2002 ; 159: 2114
29. Pollak PT, Zbuk K. Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions. Clin Pharmacol Ther. 2000 ; 68: 92-97 (Pubitemid 30609831)
30. Nudelman E, Vinuela LM, Cohen CI. Safety in overdose of quetiapine: a case report. J Clin Psychiatry. 1998 ; 59: 433 (Pubitemid 28391570)
31. Harmon TJ, Benitez JG, Krenzelok EP, et al. Loss of consciousness from acute quetiapine overdosage. J Toxicol Clin Toxicol. 1998 ; 36: 599-602 (Pubitemid 28460672)
32. Catalano G, Catalano MC, Agustines RE, et al. Pediatric quetiapine overdose: a case report and literature review. J Child Adolesc Psychopharmacol. 2002 ; 12: 355-361 (Pubitemid 36169289)
33. Strachan PM, Benoff BA. Mental status change, myoclonus, electrocardiographic changes, and acute respiratory distress syndrome induced by quetiapine overdose. Pharmacotherapy. 2006 ; 26: 578-582
34. Muller C, Reuter H, Dohmen C. Intoxication after extreme oral overdose of quetiapine to attempt suicide: pharmacological concerns of side effects. Case Report Med. 2009 ; 2009: 371698
35. Vieweg WV, Schneider RK, Wood MA. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine. Acta Psychiatr Scand. 2005 ; 112: 318-322 (Pubitemid 41382739)
36. Gajwani P, Pozuelo L, Tesar GE. QT interval prolongation associated with quetiapine (Seroquel) overdose. Psychosomatics. 2000 ; 41: 63-65 (Pubitemid 30062899)
37. Furst BA, Champion KM, Pierre JM, et al. Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin. Biol Psychiatry. 2002 ; 51: 264-265 (Pubitemid 34142639)
38. Beelen AP, Yeo KT, Lewis LD. Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exp Toxicol. 2001 ; 20: 215-219 (Pubitemid 32509942)
39. Janse A, Marijnissen RM. Quetiapine-induced bradycardia without QT interval prolongation in an elderly woman. Prim Care Companion J Clin Psychiatry. 2009 ; 11: 172-173
40. Digby G, Machaalany J, Malik P, et al. Multifactorial QT interval prolongation. Cardiol J. 2010 ; 17: 184-188
41. Kurth J, Maguire G. Pediatric case report of quetiapine overdose and QTc prolongation. Ann Clin Psychiatry. 2004 ; 16: 229-231 (Pubitemid 39665449)
42. Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000 ; 355: 1048-1052 (Pubitemid 30162807)
43. Vrtovec B, Okrajsek R, Golicnik A, et al. Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure. J Card Fail. 2005 ; 11: 684-690 (Pubitemid 41797497)
44. Xie RQ, Cui W, Liu F, et al. Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure. Int J Cardiol. 2010 ; 140: 255-257
45. VanHoose L, Sawers Y, Loganathan R, et al. Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat. Cardiovasc Diabetol. 2010 ; 9: 56
46. Alexopoulos GS, Streim J, Carpenter D, et al. Using antipsychotic agents in older patients. J Clin Psychiatry. 2004 ; 65: 5 100 103-99 102 104
47. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 ; 30: 239-245 (Pubitemid 12149145)
48. Narang P, El-Refai M, Parlapalli R, et al. Antipsychotic drugs: sudden cardiac death among elderly patients. Psychiatry (Edgmont). 2010 ; 7: 25-29